StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Novavax (NVAX) PT Raised to $257 at B.Riley/FBR
August 5, 2020 6:57 AM
B.Riley/FBR analyst Chad L. Mabry ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Ladenburg Thalmann Downgrades Novavax (NVAX) to Sell
August 5, 2020 6:34 AM
Novavax (NVAX) Reports Positive Phase 1 Data for COVID-19 Vaccine Candidate
August 5, 2020 6:24 AM
Novavax (NVAX) weekly IV at 208 into wide after market price movement
August 5, 2020 5:24 AM
UPDATE: JPMorgan Upgrades Novavax (NVAX) to Overweight
August 5, 2020 4:40 AM
After-Hours Stock Movers 08/04: (ARPO) (NVAX) (LPSN) Higher; (VAPO) (NEWR) (BYND) Lower (more...)
August 4, 2020 6:07 PM
Novavax (NVAX) Erases Post-Market Decline, Now Up 13%
August 4, 2020 5:46 PM
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
August 4, 2020 4:06 PM
Novavax (NVAX) says phase 1 data for COVID-19 vaccine candidate show it was generally well-tolerated and elicited robust antibody responses
August 4, 2020 4:06 PM
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
August 4, 2020 4:04 PM
Novavax (NVAX) Covid-19 Vaccine Induces Immune Response in First Human Study, Company Says - DJ
August 4, 2020 4:01 PM
